BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 38252039)

  • 1. Racial and Ethnic Disparities in Hepatocellular Carcinoma Treatment Receipt in the United States: A Systematic Review and Meta-Analysis.
    Wagle NS; Park S; Washburn D; Ohsfeldt R; Kum HC; Singal AG
    Cancer Epidemiol Biomarkers Prev; 2024 Apr; 33(4):463-470. PubMed ID: 38252039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial and Ethnic Disparities in Survival Among Patients With Hepatocellular Carcinoma in the United States: A Systematic Review and Meta-Analysis.
    Rich NE; Carr C; Yopp AC; Marrero JA; Singal AG
    Clin Gastroenterol Hepatol; 2022 Feb; 20(2):e267-e288. PubMed ID: 33387668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial and Ethnic Differences in Presentation and Outcomes of Hepatocellular Carcinoma.
    Rich NE; Hester C; Odewole M; Murphy CC; Parikh ND; Marrero JA; Yopp AC; Singal AG
    Clin Gastroenterol Hepatol; 2019 Feb; 17(3):551-559.e1. PubMed ID: 29859983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Race/Ethnicity and Insurance Status with Outcomes in Patients with Hepatocellular Carcinoma.
    Scaglione S; Adams W; Caines A; Devlin P; Mittal S; Singal AG; Parikh ND
    Dig Dis Sci; 2020 Jun; 65(6):1669-1678. PubMed ID: 31643036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial, Ethnic, and Socioeconomic Disparities in Curative Treatment Receipt and Survival in Hepatocellular Carcinoma.
    Wagle NS; Park S; Washburn D; Ohsfeldt RL; Rich NE; Singal AG; Kum HC
    Hepatol Commun; 2022 May; 6(5):1186-1197. PubMed ID: 34796703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Race/Ethnicity-specific Disparities in Hepatocellular Carcinoma Stage at Diagnosis and its Impact on Receipt of Curative Therapies.
    Ha J; Yan M; Aguilar M; Tana M; Liu B; Frenette CT; Bhuket T; Wong RJ
    J Clin Gastroenterol; 2016; 50(5):423-30. PubMed ID: 26583267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma.
    Mathur AK; Osborne NH; Lynch RJ; Ghaferi AA; Dimick JB; Sonnenday CJ
    Arch Surg; 2010 Dec; 145(12):1158-63. PubMed ID: 21173289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial and ethnic disparities in early treatment with immunotherapy for advanced HCC in the United States.
    Ahn JC; Lauzon M; Luu M; Noureddin M; Ayoub W; Kuo A; Sundaram V; Kosari K; Nissen N; Gong J; Hendifar A; Roberts LR; Abou-Alfa GK; Singal AG; Yang JD
    Hepatology; 2022 Dec; 76(6):1649-1659. PubMed ID: 35429171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United States.
    Artinyan A; Mailey B; Sanchez-Luege N; Khalili J; Sun CL; Bhatia S; Wagman LD; Nissen N; Colquhoun SD; Kim J
    Cancer; 2010 Mar; 116(5):1367-77. PubMed ID: 20101732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissecting disease, race, ethnicity, and socioeconomic factors for hepatocellular carcinoma: An analysis from the United States Safety Net Collaborative.
    Lee RM; Gamboa AC; Turgeon MK; Yopp A; Ryon EL; Kronenfeld JP; Goel N; Wang A; Lee AY; Luu S; Hsu C; Silberfein E; Maithel SK; Russell MC
    Surg Oncol; 2020 Dec; 35():120-125. PubMed ID: 32871546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent disparities in liver transplantation for patients with hepatocellular carcinoma in the United States, 1998 through 2007.
    Robbins AS; Cox DD; Johnson LB; Ward EM
    Cancer; 2011 Oct; 117(19):4531-9. PubMed ID: 21448933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial disparities in clinical presentation, surgical procedures, and hospital outcomes among patients with hepatocellular carcinoma in the United States.
    Chikovsky L; Kutuk T; Rubens M; Balda AN; Appel H; Chuong MD; Kaiser A; Hall MD; Contreras J; Mehta MP; Kotecha R
    Cancer Epidemiol; 2023 Feb; 82():102317. PubMed ID: 36566577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Race and Ethnicity With Live Donor Kidney Transplantation in the United States From 1995 to 2014.
    Purnell TS; Luo X; Cooper LA; Massie AB; Kucirka LM; Henderson ML; Gordon EJ; Crews DC; Boulware LE; Segev DL
    JAMA; 2018 Jan; 319(1):49-61. PubMed ID: 29297077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial/ethnic disparities in hepatocellular carcinoma treatment and survival in California, 1988-2012.
    Stewart SL; Kwong SL; Bowlus CL; Nguyen TT; Maxwell AE; Bastani R; Chak EW; Chen MS
    World J Gastroenterol; 2016 Oct; 22(38):8584-8595. PubMed ID: 27784971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disparities in Hepatocellular Carcinoma Incidence, Stage, and Survival: A Large Population-Based Study.
    Flores YN; Datta GD; Yang L; Corona E; Devineni D; Glenn BA; Bastani R; May FP
    Cancer Epidemiol Biomarkers Prev; 2021 Jun; 30(6):1193-1199. PubMed ID: 33737301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of hospital safety net designation on treatment use and survival in hepatocellular carcinoma.
    Mokdad AA; Murphy CC; Pruitt SL; Mansour JC; Marrero JA; Singal AG; Yopp AC
    Cancer; 2018 Feb; 124(4):743-751. PubMed ID: 29072773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the complexity and spectrum of racial/ethnic disparities in colon cancer management.
    Greenberg AL; Brand NR; Zambeli-Ljepović A; Barnes KE; Chiou SH; Rhoads KF; Adam MA; Sarin A
    Int J Equity Health; 2023 Apr; 22(1):68. PubMed ID: 37060065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of County-Level Upward Economic Mobility with Stage at Diagnosis and Receipt of Curative-Intent Treatment among Patients with Hepatocellular Carcinoma.
    Paro A; Dalmacy D; Tslimigras DI; Cloyd J; Ejaz A; Pawlik TM
    Ann Surg Oncol; 2022 Aug; 29(8):5177-5185. PubMed ID: 35441305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are There Differences in Postoperative Opioid Prescribing Across Racial and Ethnic Groups? Assessment of an Academic Health System.
    O'Sullivan LR; Shofer FS; Delgado MK; Agarwal AK; Humbyrd C
    Clin Orthop Relat Res; 2023 Aug; 481(8):1504-1511. PubMed ID: 36795497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial and Ethnic Disparities in Use of Novel Hormonal Therapy Agents in Patients With Prostate Cancer.
    Ma TM; Agarwal N; Mahal B; Barragan-Carrillo R; Spratt D; Rettig MB; Valle LF; Steinberg ML; Garraway I; Vapiwala N; Xiang M; Kishan AU
    JAMA Netw Open; 2023 Dec; 6(12):e2345906. PubMed ID: 38039002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.